Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison M Ainsworth, M Andersson, K Auckland, JK Baillie, E Barnes, S Beer, ... The Lancet Infectious Diseases 20 (12), 1390-1400, 2020 | 324 | 2020 |
Discovery and structure-based optimization of benzimidazole-derived activators of SOS1-mediated nucleotide exchange on RAS TR Hodges, JR Abbott, AJ Little, D Sarkar, JM Salovich, JE Howes, ... Journal of medicinal chemistry 61 (19), 8875-8894, 2018 | 52 | 2018 |
Sclerotiamide: the first non-peptide-based natural product activator of bacterial caseinolytic protease P NP Lavey, JA Coker, EA Ruben, AS Duerfeldt Journal of natural products 79 (4), 1193-1197, 2016 | 44 | 2016 |
Discovery of sulfonamide-derived agonists of SOS1-mediated nucleotide exchange on RAS using fragment-based methods D Sarkar, ET Olejniczak, J Phan, JA Coker, J Sai, A Arnold, Y Beesetty, ... Journal of Medicinal Chemistry 63 (15), 8325-8337, 2020 | 25 | 2020 |
Consequences of depsipeptide substitution on the ClpP activation activity of antibacterial acyldepsipeptides Y Li, NP Lavey, JA Coker, JE Knobbe, DC Truong, H Yu, YS Lin, ... ACS Medicinal Chemistry Letters 8 (11), 1171-1176, 2017 | 22 | 2017 |
Metformin and risk of age-related macular degeneration in individuals with type 2 diabetes: a retrospective cohort study KM Gokhale, NJ Adderley, A Subramanian, WH Lee, D Han, J Coker, ... British Journal of Ophthalmology 107 (7), 980-986, 2023 | 20 | 2023 |
Identification, mapping and relative quantitation of SARS-CoV-2 Spike glycopeptides by Mass-Retention Time Fingerprinting R Chalk, WEP Greenland, T Moreira, J Coker, SMM Mukhopadhyay, ... Communications Biology 4 (1), 934, 2021 | 5 | 2021 |
Angiotensin‐Converting enzyme inhibitors and risk of age‐related macular degeneration in individuals with hypertension A Subramanian, D Han, T Braithwaite, R Thayakaran, DT Zemedikun, ... British journal of clinical pharmacology 88 (9), 4199-4210, 2022 | 4 | 2022 |
FAS2FURIOUS: Moderate-Throughput Secreted Expression of Difficult Recombinant Proteins in Drosophila S2 Cells JA Coker, VL Katis, M Fairhead, A Schwenzer, SB Clemmensen, ... Frontiers in Bioengineering and Biotechnology 10, 871933, 2022 | 4 | 2022 |
Pharmacologic treatments for dementia and the risk of developing age-related macular degeneration J Wang, C Antza, WH Lee, J Coker, PA Keane, AK Denniston, ... JAMA network open 7 (10), e2441166-e2441166, 2024 | 2 | 2024 |
Discovery and Characterization of Selective, First-in-Class Inhibitors of Citron Kinase JJ Maw, JA Coker, T Arya, CM Goins, D Sonawane, SH Han, MG Rees, ... Journal of Medicinal Chemistry 67 (4), 2631-2666, 2024 | 2 | 2024 |
Fibrinogen-like globe domain of human Tenascin-C (hFBG-C) ATEP TEP Group, 2020 | 1 | 2020 |
WD repeat domain 5 (WDR5) inhibitors: a patent review (2016-present) JA Coker, SR Stauffer Expert Opinion on Therapeutic Patents, 2025 | | 2025 |
CDK9 inhibition by dinaciclib is a therapeutic vulnerability in epithelioid hemangioendothelioma AV Pobbati, A Burtscher, N Rajaram Siva, A Hallett, T Romigh, K Che, ... Clinical Cancer Research 30 (18), 4179-4189, 2024 | | 2024 |
Association of sildenafil use with age-related macular degeneration: a retrospective cohort study JED Han, A Subramanian, WH Lee, J Coker, AK Denniston, ... BMJ Open Ophthalmology 9 (1), e001525, 2024 | | 2024 |
A Grand Evasion: How Corporations Deprive Workers, Government, and Society by Widespread Tax Avoidance J Coker | | 2016 |
Between a Poor and a Poorer Place: Why Welfare Should View the Labor Market as the Problem Rather than the Solution to Poverty J Coker | | 2016 |
Chemoactivation of a bacterial protease: Expanding the molecular arsenal and exploring therapeutic potential G Peddabuddi, JA Coker, C Zhou, NP Lavey, AS Duerfeldt Planta Medica 81 (11), PS5, 2015 | | 2015 |
2015 THURJ: The Honors Undergraduate Research Journal A Pemberton, M Doan, J Coker, H Van Amburgh, E Marrs, M Rodriguez, ... | | 2015 |
Weapons of Mass Destruction: OTC Derivatives and the 2008 Financial Crisis J Coker | | 2015 |